Genomtec SA (GMT) Stock Price & News

GMT:WSE

Genomtec SA

PLN 3.02

-4.13%

(-0.13) 1D

Oct 2, 5:00:00 PM GMT+2 · PLN

All symbols

	Symbol	Price	Change	% Change

Last report

Sep 30, 2026

Fiscal period

Q2 2026

EPS / Est. (PLN)

- / -

Revenue / Est. (PLN)

11.00K / -

Fiscal Q2 2026 earnings call

Waiting for the earnings call

At a glance

Insights from the latest news and reports

Previous reportsAll values in PLN

Loading Previous Earnings...

All values in PLN	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	4.00K	4.00K	16.00K	11.00K
Cost of goods sold	1.57M	1.47M	2.02M	2.08M
Cost of revenue	1.57M	1.47M	2.02M	2.08M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	1.31M	1.57M	1.47M	1.66M
Operating expense	952.00K	-820.00K	137.00K	-43.00K
Total operating expenses	2.52M	647.00K	2.16M	2.03M
Operating income	-2.51M	-643.00K	-2.14M	-2.02M
Other non operating income	-	-483.00K	1.00K	19.00K
EBT including unusual items	-2.57M	-1.15M	-2.18M	-2.07M
EBT excluding unusual items	-2.57M	-1.15M	-2.18M	-2.07M
Income tax expense	6.00K	-57.00K	17.00K	-
Effective tax rate	-0.23%	4.95%	-0.78%	-
Other operating expenses	-360.00K	-2.39M	-1.34M	-1.70M
Net income	-2.57M	-1.10M	-2.20M	-2.07M
Net profit margin	-64,300.00%	-27,375.00%	-13,725.00%	-18,827.27%
Earnings per share	-	-	-	-
Interest and investment income	10.00K	10.00K	10.00K	-
Interest expense	-41.00K	-29.00K	-35.00K	-81.00K
Net interest expenses	-31.00K	-19.00K	-25.00K	-81.00K
Depreciation and amortization charges	-	-	-	-
EBITDA	-1.84M	-338.00K	-1.44M	-1.33M
Gain or loss from assets sale	-	448.00K	-	-

Finance